Press "Enter" to skip to content

‘The Cat Is Safe — For Now’: What We Heard This Week

“The cat is safe — for now.” — Pet owner Laith Al Momani, MD, of East Tennessee State University in Johnson City, on his group’s finding that exposure to pets may boost the risk for irritable bowel syndrome.

“It rearranges the deck chairs on the Titanic.” — James Gelfand, senior vice president for health policy at the ERISA Industry Committee (ERIC), on using binding arbitration to fix “surprise billing.”

“It’s not kooky, but it does have some risks.” — Alan Schatzberg, MD, of Stanford University School of Medicine in Stanford, California, discussing intranasal esketamine spray at the American Psychiatric Association’s annual meeting.

“Pharma is claiming it spends all this money on R&D but it won’t show us the books, so at a certain point, count me as skeptical.” — Rep. Pete Welch (D-Vt.), on drugmakers’ lack of transparency.

“We ask, what is he so afraid of?” — Senate Minority Leader Chuck Schumer (D-N.Y.), on Senate Majority Leader Mitch McConnell (R-Ky.), turning the Senate into a “legislative graveyard.”

“Continuous therapy forever … you don’t feel like you’re in remission, you don’t ever go away from being a patient, ever.” — Jennifer Brown, MD, PhD, of Dana-Farber Cancer in Boston, on selecting ibrutinib (Imbruvica) for first-line treatment in chronic lymphocytic leukemia.

“It’s not rewarding; it’s not methadone or THC.” — Yasmin Hurd, PhD, of the Icahn School of Medicine at Mount Sinai in New York City, on study findings that cannabidiol reduced opioid cravings and anxiety among heroin users.

“We need to be more proactive in terms of looking at individuals before they start cancer therapy.” — Susan Dent, MD, of Duke University in Durham, North Carolina, on oncologists getting more involved in the field of cardio-oncology.

“This research is important because as part of a community colon cancer screening program, more individuals are likely to complete their bowel preps without compromising the ability of the endoscopist to perform a high quality colonoscopy.” — Gautam Mankaney, MD, of the Cleveland Clinic, on results from a study in the Bowel Cleansing National Initiative (BClean).